Sands Capital is an active, long-term investor in innovative businesses globally. Their approach combines fundamental analysis with creative thinking to identify growth businesses.

Sands Capital

Sands Capital | 12,800 followers on LinkedIn. Active, long-term investors in leading innovative businesses, globally. | Sands Capital is an active, long-term investor in leading innovative growth businesses, globally. Our approach combines analytical rigor and creative thinking to identify high-quality growth businesses that are creating the future. Through an integrated investment platform spanning venture capital, growth equity and public equity, we provide growth capital solutions to institutions and fund sponsors in more than 40 countries.

Venture Partner at Sands Capital Management

Gene Riechers

FinTech Entrepreneur

Jeff Lewis

Chris Linthwaite

Managing Partner at Sands Capital Ventures

Scott Frederick

Despite the short-term pressure on some software stocks, the long-term opportunity in select businesses remains strong. Learn why our analysts see potential in businesses offering mission-critical, multiproduct platforms with fast time-to-value. https://lnkd.in/e4fd8V_R #verticalsoftware #software

Sands Capital believes we have a responsibility to engage with our companies to understand and influence the potential impact of their operations. As part of our focus on the fight against #modernslavery , we continue to partner with Hope for Justice and Slave-Free Alliance to better understand and seek to mitigate modern slavery risks at both the portfolio and operational levels at our firm. Learn more from Hope for Justice about this global issue: https://lnkd.in/em45_jUF

We are proud to lead the Series D financing for Cytovale , an innovative medical diagnostics leader focused on advancing early detection technologies. This funding will accelerate commercial and operational expansion of Cytovale’s IntelliSep, building on its early clinical success. We’re thrilled to support Ajay Shah , Henry Tse , and the entire team as they continue to transform the diagnoses of fast-moving and immune-mediated diseases. Learn more about Cytovale’s role as an innovator in the health care industry here: https://lnkd.in/dMtPX9gT

Change can create uncertainty in financial markets, but it also has the potential to unlock opportunities for many of the businesses we own. Tune in to hear Sr. Portfolio Manager Dave Levanson, CFA, discuss the on-going journey of these businesses, why we continued to own them through tough times, and what we can expect from them going forward. https://lnkd.in/eKaK5DfJ

Investing for the long term takes courage and the support of a culture rooted in trust. Find out how Sands Capital Director of Research Michael Raab , CFA, keeps his research team focused on what matters most. https://lnkd.in/eKqxrmRV

Portfolio Manager and Sr. Research Analyst Daniel Pilling joined Caroline Hyde and Edward Ludlow on Bloomberg to discuss Sands Capital’s outlook on NVIDIA ’s long-term growth drivers and the company’s role in the broader evolution of artificial intelligence ahead of their Q2 earnings report. Hear more about our views on remaining competitive in the semiconductor industry amid a global acceleration in demand for compute power: https://lnkd.in/ePD_mmwP Disclosures: https://lnkd.in/e9k3T4-M

Generative artificial intelligence could strengthen the leadership positions of businesses that can invest in the infrastructure, data, and talent needed to run this transformative technology. Learn why we believe owning industry-leading companies is critical to value creation. https://lnkd.in/eEddXYtv

Sands Capital Management, LLC is pleased to be a signatory to the UK Stewardship Code. This designation reflects our commitment to responsible investment on behalf of clients globally. Learn more about the code and our stewardship work. https://lnkd.in/ersJXAmd

We are delighted to co-lead Anduril Industries ' Series F funding round, a significant milestone in its ongoing mission to disrupt the defense industry and provide modernized defense capabilities for the U.S. and its Allies. Our respect for Anduril's leadership team is longstanding, particularly its ability to consistently execute against their objectives. We are excited to champion Anduril's journey and foster our long-term partnership. Learn more about the significant steps Anduril is taking to modernize the defense industry: https://lnkd.in/efzxsFQy

We are thrilled to participate in the most recent financing round of Credo AI . We are excited to watch Navrina Singh , Eli Chen , and the team as they continue to reinforce their commitment to enabling organizations worldwide to adopt AI responsibly while driving innovation and operational efficiency. https://lnkd.in/eSG7KFty

Metric
Company Name	Sands Capital
Symbol
MSH ID	COM:SANDSCAPITALVENTURES
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Investment Management
Country	US
Stage
Employee Count
Website	sandscapitalventures.com
LinkedIn	sands-capital-management
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SAND

COM:SANDSCAPITALVENTURES

Sands Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue